These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
422 related items for PubMed ID: 16699277
1. NSAID-associated dyspepsia and ulcers: a prospective cohort study in primary care. Hollenz M, Stolte M, Leodolter A, Labenz J. Dig Dis; 2006; 24(1-2):189-94. PubMed ID: 16699277 [Abstract] [Full Text] [Related]
2. Celecoxib compared with lansoprazole and naproxen to prevent gastrointestinal ulcer complications. Lai KC, Chu KM, Hui WM, Wong BC, Hu WH, Wong WM, Chan AO, Wong J, Lam SK. Am J Med; 2005 Nov; 118(11):1271-8. PubMed ID: 16271912 [Abstract] [Full Text] [Related]
3. [Gastrointestinal complications under NSAID treatment in the doctor's office]. Hollenz M, Labenz J. MMW Fortschr Med; 2004 Dec 02; 146(49):42, 44. PubMed ID: 15646716 [Abstract] [Full Text] [Related]
4. Impact of non-steroidal anti-inflammatory drug and aspirin use on the prevalence of dyspepsia and uncomplicated peptic ulcer disease. Voutilainen M, Mäntynen T, Färkkilä M, Juhola M, Sipponen P. Scand J Gastroenterol; 2001 Aug 02; 36(8):817-21. PubMed ID: 11495076 [Abstract] [Full Text] [Related]
5. Gastroprotective therapy and risk of gastrointestinal ulcers: risk reduction by COX-2 therapy. Wolfe F, Anderson J, Burke TA, Arguelles LM, Pettitt D. J Rheumatol; 2002 Mar 02; 29(3):467-73. PubMed ID: 11908558 [Abstract] [Full Text] [Related]
6. Underutilization of preventive strategies in patients receiving NSAIDs. Sturkenboom MC, Burke TA, Dieleman JP, Tangelder MJ, Lee F, Goldstein JL. Rheumatology (Oxford); 2003 Nov 02; 42 Suppl 3():iii23-31. PubMed ID: 14585915 [Abstract] [Full Text] [Related]
7. Ulcer recurrence in high-risk patients receiving nonsteroidalanti-inflammatory drugs plus low-dose aspirin: results of a post HOC subanalysis. Goldstein JL, Huang B, Amer F, Christopoulos NG. Clin Ther; 2004 Oct 02; 26(10):1637-43. PubMed ID: 15598480 [Abstract] [Full Text] [Related]
12. The role of proton pump inhibitors in NSAID-associated gastropathy and upper gastrointestinal symptoms. Laine L. Rev Gastroenterol Disord; 2003 Oct 02; 3 Suppl 4():S30-9. PubMed ID: 14671512 [Abstract] [Full Text] [Related]
19. Proton-pump inhibitors are associated with a reduced risk for bleeding and perforated gastroduodenal ulcers attributable to non-steroidal anti-inflammatory drugs: a nested case-control study. Vonkeman HE, Fernandes RW, van der Palen J, van Roon EN, van de Laar MA. Arthritis Res Ther; 2007 Apr 30; 9(3):R52. PubMed ID: 17521422 [Abstract] [Full Text] [Related]